Preprint Article Version 1 This version is not peer-reviewed

Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay between HBV- and HCC-Related Molecular Processes in Human Liver: Biological Significance and Management in COVID-19 Patients

Version 1 : Received: 3 November 2024 / Approved: 3 November 2024 / Online: 4 November 2024 (11:15:43 CET)

How to cite: Colonna, G. Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay between HBV- and HCC-Related Molecular Processes in Human Liver: Biological Significance and Management in COVID-19 Patients. Preprints 2024, 2024110138. https://doi.org/10.20944/preprints202411.0138.v1 Colonna, G. Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay between HBV- and HCC-Related Molecular Processes in Human Liver: Biological Significance and Management in COVID-19 Patients. Preprints 2024, 2024110138. https://doi.org/10.20944/preprints202411.0138.v1

Abstract

The Spike subunit S1 of SARS-CoV-2 was discovered to be free in our organism, during and after covid and after vaccination. One of its properties is that of interacting one-to-one with human proteins. S1 interacts one-to-one with 12 specific human proteins in the liver. We used these proteins as seeds to extract from the human proteome their functional relationships by enrichment. The interactome representing the set of metabolic activities in which they are involved shows several molecular processes (KEGG) connected with HBV (hepatitis B) and HCC (hepatocellular carcinoma). The number of genes/proteins involved is quite high. Literature data report many cases of patients with COVID where HBV was activated or progressed to cancer. Therefore, we analyzed the interactome with several approaches to understand whether the two pathologies have inde-pendent progressions or a common progression. All our efforts consistently showed that the mo-lecular processes involving both HBV and hepatocellular carcinoma are significantly present in all approaches we used, making it difficult to extract any useful information about their fate. All this has led us to consider that S1-induced molecular changes do not operate in isolation. The interac-tome shows the viral potentialities that, to be expressed or not, must interact with the specific bio-logical context of the patient's phenotype. A series of suggestions arises for using this knowledge in patient management from these considerations.

Keywords

Spike subunit S1 of SARS-CoV-2; covid-19; liver pathologies; interactomics

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.